DR. DAVID U'PRICHARD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2010-04-23 "Dr. David U'Prichard 61 Chairman of the Board of Directors" and "The Compensation and Organization Development Committee currently has three members: Dr. Christopher Henney (Chairman), Dr. Nicholas Bacopoulos and Dr. David U'Prichard."
2010-09-21 Dr. U'Prichard serves as the Chairman of our Board of Directors... The Compensation and Organization Development Committee currently has three members: Dr. Christopher Henney (Chairman), Dr. Nicholas Bacopoulos and Dr. David U'Prichard.
2012-04-19 "Dr. David U'Prichard 63 Chairman of the Board of Directors; Class 2 Director"; "The Compensation and Organization Development Committee currently has three members: Dr. Christopher Henney (Chairman), Dr. Nicholas Bacopoulos and Dr. David U'Prichard."; "The Nominating and Corporate Governance Committee has four members, Sir John Banham (Chairman), Lloyd Sems, Daniel K. Spiegelman and Dr. David U'Prichard."; and "David U'Prichard, Ph.D. ... Total ($) 139,487"
2013-04-03 Dr. David U'Prichard ... 64 ... Chairman of the Board of Directors; Class 2 Director ... Compensation and Organization Development Committee currently has three members ... Dr. David U'Prichard ... Nominating and Corporate Governance Committee ... total ... 108,500

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04